Global Clinical Chemistry Analyzers Market to Reach a Value of US$ 16.3 Bn by 2027, Expanding at a CAGR of 4% Over 2019 and 2027: Transparency Market Research
The growing relevance of pathological processes within the medical industry has brought clinical chemistry under the spotlight of attention. Presence of a robust infrastructure for clinical research blows life into the medical and healthcare industries
ALBANY, New York, March 12, 2020 /PRNewswire/ --The healthcare industry has attracted the attention of global analysts, scientists, and research scholars. Growth across this industry is a direct function of advancements in medical testing, pathological procedures, and biological research. The development of a seamless domain to analyse biological indicators could unravel an era of unhindered advancements in the healthcare industry. Clinical chemistry analyzers are an important component of the research ecosystem deployed across biochemical industry. Besides, the direct relationship of clinical chemistry analyzers to the development of medical therapies has popularised the formers. It is expected that the global clinical chemistry analyzers market would tread along a lucrative trajectory in the times to follow. The market share of private research institutes in the global clinical chemistry analyzers market is set to increase as these entities are more liberal in their spending propensities.
It is expected that the global clinical chemistry analyzers market would expand at a steady CAGR of 4% over the period between 2019 and 2027. Besides, the total revenues within the global clinical chemistry analyzers market is expected to touch US$ 16.3 Bn by 2027, growing from a value of 11.3 Bn in 2018.
The dearth of medical research institutes that offer clinical chemistry as a primary service is behind the steady rate of market growth. However, the medical fraternity is shifting its focus from superficial and macroscopic research to detailed and pinpoint analysis.
Decoding the Medical Industry to Understand the Relevance of Clinical Chemistry
The focus of the medical industry on microscopic research shall bring clinical chemistry analyzers under the spotlight of attention, giving an impetus to market growth
In the absence of viable technologies for analysing pathological samples, use of clinical chemistry remains a sought-after subject across the healthcare sector
Development of new classes of drugs is preceded by extensive research and testing of pharmaceutical excipients, clinical indicators, and biological fluids. This is an important dynamic of growth within the global clinical chemistry analyzers market.
Gather comprehensive insights about the trends and opportunities pertaining to the Clinical Chemistry Analyzers Market (Product: Panels & Reagents and Analyzers; Technology: Semi-automatic and Fully Automatic; Modality: Centralized and Decentralized; and End User: Hospitals, Diagnostic Centers, academic Research Institutes, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Global Clinical Chemistry Analyzers Market: Growth Drivers
The healthcare industry is leaving no stone unturned in offering optimized services to the patients. However, the performance of the healthcare industry largely depends on its support mechanism consisting of prudent pharmaceutical research, clinical testing, and biochemical analysis. Medical biochemistry is an important area of research, and investments in this area shall drive demand within the global clinical chemistry analyzers market.
Drug development has gathered pace in recent times, and has supported the growth of the global clinical chemistry analyzers market
Development of new research facilities, especially across the developing regions, has caused positive disruptions in the medical sector
Investments in medical research and analysis have increase as governments and stakeholders see profitable gains in this industry
The advent of digital technologies in biochemical research has enabled quicker and easier retrieval of results
Challenges Pertaining to Execution of Research Lines across Medical Institutes
Despite favourable growth across the research industry, the following factors hamper growth within the global clinical chemistry analyzers market:
Non-conformity of traditional research institutes to modern-day, advanced practices for clinical research has created loopholes in the global clinical chemistry industry
Unavailability of state-of-the-art research facilities in remote regions deprives small medical institutes from the virtues of clinical chemistry
Large investors are reluctant to put their money in research projects, mainly due to the fear of being undercompensated if the research does not succeed
The medical research sector in the US has constantly aimed at improving its internal processes, whilst creating a robust pathway for revenue generation. This trend has given a thrust to the growth of the North America clinical chemistry analyzers market.
Medical tourism to India and China has increase in recent times. This trend has popularised the importance of clinical chemistry analyzers in the region. Recent outbreak of the coronavirus has also led to increased focus on clinical chemistry
Countries in the Middle East are increasing their investments in medical research, and are causing positive disruptions in healthcare. This trend shall help driving demand within the regional clinical chemistry analyzers market.
The leading vendors in the global clinical chemistry analyzers market are focused on informing medical research institutes about the perks of using their products. These vendors have developed high-end analyzers and indicators that can be used for analysis and testing within the medical industry. Some of these companies are Danaher Corporation, F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd, and Siemens Healthineers.
The chemical chemistry analyzers market is segmented as follows;
Clinical Chemistry Analyzers Market, by Product
Panels & Reagents
Clinical Chemistry Analyzers Market, by Technology
Clinical Chemistry Analyzers Market, by Modality
Clinical Chemistry Analyzers Market, by End User
Academic Research Institutes
Clinical Chemistry Analyzers Market, by Region
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:
Point-of-care Diagnostics Market - The global market for point of care (PoC) diagnostics is currently experiencing a highly promising growth in recent years. This growth can be mainly attributed to growing preference of patients to undergo these tests. Another important factor that is helping to drive the growth of the global market is the constant technological advancements occurring in the domain.
Molecular Diagnostics Market - The global molecular diagnostics market stood at US$7.1 bn in 2015 and is projected to garner a CAGR of about 11.6% from 2016 to 2025. By the end of the period, the global worth will be equal to US$18.9 bn. The report segments the molecular diagnostics market on the basis of end user, technology, and application, in addition to the geography parameter. Of all, the polymerase chain reaction has gained extensive popularity. This is attributed to the cost-effectiveness, which in turn, is due to the simple instrumentation and infrastructure required for PCR-based techniques.
Immunoassay Market - According to the research study, the global market for immunoassay stood at US$ 16.54 Bn in 2017, is anticipated to reach a value of US$ 28.61 Bn by the end of 2026. The market is expected to register a strong 6.20% CAGR between 2018 and 2026. A substantial rise in the cases of infectious and chronic disease and the rise in the use of immunoassays in oncology are likely as the main factors that are projected to support the development of the market in the coming years. The rising geriatric population and the technological advancements in this area are estimated to accelerate the growth of the overall market in the next few years. Moreover, the high development in biopharmaceutical and biotechnology industries is another factor that is predicted to create potential growth opportunities over the coming years.
Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."